Heterocyclic compounds

Details for Australian Patent Application No. 2003224546 (hide)

Owner AstraZeneca AB

Inventors Chang, Hui-Fang; Phillips, Eifion

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003224546

PCT Number PCT/SE03/00615

PCT Pub. Number WO2003/087104

Priority 0203606-9 04.12.02 SE; 0201185-6 18.04.02 SE

Filing date 15 April 2003

Wipo publication date 27 October 2003

Acceptance publication date 6 November 2008

International Classifications

C07D 491/22 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

A61P 25/34 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 453/00 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 0203606-9 04.12.02 SE; 0201185-6 18.04.02 SE

4 December 2003 Application Open to Public Inspection

  Published as AU-B-2003224546

6 November 2008 Application Accepted

  Published as AU-B-2003224546

5 March 2009 Standard Patent Sealed

11 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003224547-New 2-substituted -1,3-thiazole compounds

2003224545-Thienyl compounds